This text of South Dakota § 58-29E-15 (Discrimination prohibited--340B entity--Exclusions.) is published on Counsel Stack Legal Research, covering South Dakota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Neither a pharmacy benefit manager nor a pharmacy benefit manager affiliate may, directly or indirectly, discriminate against a 340B entity or a pharmacy under contract with a 340B entity, on the basis that the 340B entity or a pharmacy under contract with a 340B entity participates in the 340B drug discount program by imposing terms or conditions that differ from a similarly situated entity that does not participate in the 340B drug discount program. Discriminatory acts include:
(1)Reimbursing a 340B entity at a rate lower than that paid for the same drug to a pharmacy that has a similar prescription volume but is not a 340B entity;
(2)Assessing a fee or cost, imposing a charge back, or imposing any other adjustment against a 340B entity, on the ground that the 340B entity partici
Free access — add to your briefcase to read the full text and ask questions with AI
Neither a pharmacy benefit manager nor a pharmacy benefit manager affiliate may, directly or indirectly, discriminate against a 340B entity or a pharmacy under contract with a 340B entity, on the basis that the 340B entity or a pharmacy under contract with a 340B entity participates in the 340B drug discount program by imposing terms or conditions that differ from a similarly situated entity that does not participate in the 340B drug discount program. Discriminatory acts include: (1) Reimbursing a 340B entity at a rate lower than that paid for the same drug to a pharmacy that has a similar prescription volume but is not a 340B entity; (2) Assessing a fee or cost, imposing a charge back, or imposing any other adjustment against a 340B entity, on the ground that the 340B entity participates in the 340B drug discount program; (3) Restricting access by a 340B entity to a pharmacy network on the ground that the 340B entity participates in the 340B drug discount program; (4) Requiring that a 340B entity contract with a specific pharmacy or health coverage plan as a condition of participating in a pharmacy network; (5) Imposing a new restriction or an additional charge on a patient who elects to receive a prescription drug through a 340B entity; (6) Restricting the method by which a 340B entity may dispense or deliver 340B drugs; (7) Auditing a 340B entity, as provided for under § 58-29F-1 , more frequently than similarly situated entities that do not participate in the 340B drug discount program; (8) Refusing to provide reimbursement or coverage for 340B drugs that are part of a formulary; (9) Basing prescription drug benefit coverage or formulary decisions on: (a) The 340B status of a drug, including price or availability; or (b) Whether a dispensing pharmacy participates in 340B drug pricing; (10) Imposing on a 340B entity any requirement or restriction that interferes with the entity’s ability to maximize the value of the discounts obtained through participation in the 340B drug discount program; and (11) Imposing on a 340B entity any contractual terms and conditions that differ from those imposed on a similarly situated entity that is not a 340B entity.